The European Clinical, Molecular, and Pathological (ECMP) Criteria and the 2007/2008 Revisions of the World Health Organization for the Diagnosis, Classification, and Staging of Prefibrotic Myeloproliferative Neoplasms Carrying the JAK2V617F Mutation

The European Clinical, Molecular, and Pathological (ECMP) Criteria and the 2007/2008 Revisions of the World Health Organization for the Diagnosis, Classification, and Staging of Prefibrotic Myeloproliferative Neoplasms Carrying the JAK2V617F Mutation

OBJECTIVE: The prefibrotic stages of JAK2V617F essential thrombocythemia (ET) and JAK2V617F polycythemia vera (PV) can easily be diagnosed clinically without use of bone marrow biopsy histology. We assessed the 2008 WHO and European Clinical, Molecular, and Pathological (ECMP) criteria for the diagn...

Full description

Bibliographic Details
Main Authors: Jan Jacques Michiels, Fibo Ten Kate, King H. Lam, Wilfried Schroyens, Zwi Berneman, Hendrik De Raeve
Format: Article
Language:English
Published: Galenos Publishing House 2014-08-01
Series:Turkish Journal of Hematology
Subjects:
myeloproliferative disorders
myeloproliferative neoplasm
essential thrombocythemia
polycythemia vera
primary myelofibrosis
jak2v617f mutation
bone marrow histopathology
red cell mass
erythrocyte count
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-78476

Internet

https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-78476

Similar Items